Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial
Conclusions/interpretationPOWER2DM improves HbA1c levels compared with usual care in those with type 2 diabetes, improves QoL in those with type 1 diabetes, improves diabetes self-management in those with type 1 and type 2 diabetes, and is well accepted in daily life.Trial registrationClinicalTrials.gov NCT03588104.FundingThis study was funded by the European Union ’s Horizon 2020 Research and Innovation Programme (grant agreement number 689444).Graphical Abstract
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Grants | Netherlands Health | Psychology | Spain Health | Study